Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis
出版年份 2022 全文链接
标题
Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis
作者
关键词
-
出版物
LANCET ONCOLOGY
Volume 23, Issue 4, Pages 514-520
出版商
Elsevier BV
发表日期
2022-03-08
DOI
10.1016/s1470-2045(22)00073-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 2020 FDA drug approvals
- (2021) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020
- (2021) Patrick Liu et al. JAMA Network Open
- Paying for Prescription Drugs in the New Administration
- (2021) Aaron S. Kesselheim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe
- (2021) Kerstin N. Vokinger et al. JAMA Oncology
- Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019
- (2021) Meera Dhodapkar et al. JAMA Network Open
- Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis
- (2020) Kerstin N Vokinger et al. LANCET ONCOLOGY
- Lower Prices and Greater Patient Access — Lessons from Germany’s Drug-Purchasing Structure
- (2020) James C. Robinson NEW ENGLAND JOURNAL OF MEDICINE
- Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios
- (2020) Yevgeniy Goryakin et al. PLoS One
- It’s Still The Prices, Stupid: Why The US Spends So Much On Health Care, And A Tribute To Uwe Reinhardt
- (2019) Gerard F. Anderson et al. HEALTH AFFAIRS
- The Impact Of Price Regulation On The Availability Of New Drugs In Germany
- (2019) Ariel D. Stern et al. HEALTH AFFAIRS
- Competition and price among brand-name drugs in the same class: A systematic review of the evidence
- (2019) Ameet Sarpatwari et al. PLOS MEDICINE
- Comparative Approaches to Drug Pricing
- (2019) So-Yeon Kang et al. Annual Review of Public Health
- Accessibility of cancer drugs in Switzerland: Time from approval to pricing decision between 2009 and 2018
- (2019) Kerstin N. Vokinger et al. HEALTH POLICY
- Trajectories of Injectable Cancer Drug Costs After Launch in the United States
- (2018) Noa Gordon et al. JOURNAL OF CLINICAL ONCOLOGY
- Steady Increase In Prices For Oral Anticancer Drugs After Market Launch Suggests A Lack Of Competitive Pressure
- (2016) Caroline S. Bennette et al. HEALTH AFFAIRS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started